Interactive Response Technology (IRT)- IXRS®3


Used in more than 2,000 clinical trials and at over 130,000 sites around the world

IRT Solutions AlmacOver the past several years, clinical trials have become increasingly intricate. Study sponsors now aim to satisfy multiple objectives within a single, more complex protocol. As the level of complexity grows, it’s imperative that the technology employed to capture this critical data keeps up. We have earned a reputation for providing a level of flexibility through our IRT software that is unmatched in the industry.

Available in multiple modalities, our market-leading solution for patient randomisation and trial supply management is the most configurable and customisable interactive response technology available. From Phase I through to IV, simple designs to complex adaptive trials, IXRS®3 easily accommodate any permutation of study objectives.

Expert Tip: IRT for Risk-Based Monitoring

IRT- Interactive Response Technology for Risk Based Monitoring at AlmacApplied effectively, today’s sophisticated Interactive Response Technology (IRT) can enable study teams to boost their risk-based monitoring strategy through additional proactive metrics to monitor clinical trial integrity and site performance.  Click here to get to know how Almac’s IRT, IXRS® 3’s capabilities fit squarely with the FDA’s description of risk-based monitoring.


IXRS®3 - Intuitive, sophisticated and reliable Interactive Response Technology

IXRS®3 offers an intuitive and logical way to manage the key components of clinical trials including: screening, randomisation, dosing, drug supply/inventory management, patient tracking, clinical outcomes assessments and more - providing access to pertinent data points and actionable insight across studies and programs.

Our sophisticated supply management capabilities, allow our Project Managers to collaborate with sponsor teams to find the optimal balance of inventory to minimise supply costs and  maximise successful patient resupply throughout your study.

Contact Us